专利 等待形式审查

NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Overview

本页收录老挝专利「NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)」的公开登记要点,由 AiCuris GmbH & Co.KG 于 2020-04-29 提交申请,当前状态为等待形式审查。标识字段包括:申请号 P/806;DIP 编号 LAP806;主管局代码 LA;保护类型 Patent - PCT National Phase。时间线要点:公开/公告日 2026-01-30。技术或外观分类记载为 A61K 31/496、C07D 403/06。发明人 / 设计人包括 BARRIOS, Esther Alza、BONSMANN, Susanne、DETTA, Elena、DONALD, Alastair、GOLDNER, Thomas 等。代理机构 / 代理人记载为 Lao Trademark Agency。公开摘要提示:The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhib…。

专利 老挝 DIP

申请号 P/806
申请日期 2020-04-29
申请人 AiCuris GmbH & Co.KG
代理机构 Lao Trademark Agency
类别 A61K 31/496 · C07D 403/06

图样

下载

基础信息

类型
专利
申请号
P/806
状态
等待形式审查
申请人
AiCuris GmbH & Co.KG
代理机构
Lao Trademark Agency
申请日期
2020-04-29
公开/公告日
2026-01-30
国际分类
A61K 31/496 · C07D 403/06
商品 / 服务

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查 进行中
  3. 实质审查
  4. 公开
  5. 授权

关联分析

LaoBiz 企业数据库联动

摘要

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

登录 LaoBiz

使用注册邮箱登录您的账号

或使用

使用 Google 登录

还没有账号?

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。